Title of article
Breaking Down Tumor Defenses Review Article
Author/Authors
David Hockenbery، نويسنده ,
Issue Information
ماهنامه با شماره پیاپی سال 2004
Pages
2
From page
417
To page
418
Abstract
BCL-2 antiapoptotic proteins are considered ripe targets for anticancer drugs, yet only recently have small molecule inhibitors emerged. Beccatini and colleagues find a BCL-XL inhibitor in the guise of a familiar natural product, gossypol. An analog, apogossypol, is a relatively selective BCL-XL antagonist.
Journal title
Chemistry and Biology
Serial Year
2004
Journal title
Chemistry and Biology
Record number
1158804
Link To Document